Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AC-101 in Moderately to Severely Active Ulcerative Colitis
NCT07755241Phase 2Recruiting
- Sponsor
- Accro Bioscience
- Start
- Sep 2026
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
A Phase 2 trial of AC-101 in ulcerative colitis (UC), sponsored by Accro Bioscience. Started Sep 2026; status: recruiting.
02
Drugs
AC-101
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT07755241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07755241.